Ticker Scorecard - INBX Basics Company: Inhibrx, Inc. IPO Date: August 19, 2020 Sector: Healthcare Industry: Biotech Market Cap: $186.88M Activated in VL: True Average Daily Range Avg Daily Range: $0.82 | 3.50% Avg Daily Range (30 D): $0.43 | 3.04% Avg Daily Range (90 D): $0.33 | 2.26% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): .07M Avg Daily Volume (90 D): .06M Trade Size Avg Trade Size (Sh.): 64 Avg Trade Size (Sh.) (30 D): 52 Avg Trade Size (Sh.) (90 D): 53 Institutional Trades Total Inst.Trades: 1,231 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $1.91M Avg Inst. Trade (90 D): $1.08M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.17M Avg Closing Trade (30 D): $1.91M Avg Closing Trade (90 D): $1.91M Avg Closing Volume: 82.23K     News Jul 23, 2024 @ 9:01 AM Inhibrx stock rated 'Market Perform' by JMP after ... Source: Emilio Ghigini Feb 28, 2024 @ 3:25 PM Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue... Source: Zacks Equity Research Feb 22, 2024 @ 10:15 PM BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings a... Source: Zacks Equity Research Jan 25, 2024 @ 2:26 PM Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY... Source: Kinjel Shah Jan 24, 2024 @ 3:42 PM Biotech Stock Roundup: GILD Down on Study Results,... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.84 $127.1 Diluted EPS $-2.84 $125.48 Revenue $ $ M $ .1M Gross Profit $ $ $ Net Income / Loss $ $ -43.86M $ 1.86B Operating Income / Loss $ $ -46.8M $ -160.9M Cost of Revenue $ $ $ Net Cash Flow $ $ -30.53M $ PE Ratio